Because pharmacological blockade or knock-down of mGlu3 receptors mimicked LPD/IL-1β inducing a pro-inflammatory microglial phenotype, it is reasonable to assume that the downregulation of mGlu3 receptors may contribute to neuroinflammation and the ensuing neurological complications associated with IUGR. This evidence concerns the gene IL1B and fetal growth restriction.